Meet Proteona at LifeTime: Basel, 31 Oct. 2019

Meet Proteona at Meet Proteona at the LifeTime meets industry conference in Basel Myri Roet from Pixabay

Meet Proteona at the “LifeTime meets industry” conference in Basel, Switzerland

Innovative AI-driven genomic and proteomic analysis platform for improving cell therapy and immuno-oncology

Meet Proteona at the “LifeTime meets industry” conference, taking place on the 31st of October in Basel, Switzerland. The LifeTime Initiative aims to understand the underlying mechanisms of key diseases on a cellular and molecular level, so that doctors will be able to improve patient diagnosis and provide personalized treatment. It is built on key technologies including single cell analysis, artificial intelligence, and patient-derived organoids models.

Take the opportunity to meet with leading researchers and industry partners. Talk to us to find out how Proteona can contribute the LifeTime vision by applying single cell proteogenomics to solve clinical questions.

Event details

Schedule a meeting

For media queries, please contact:

Dr Andreas Schmidt

About Proteona

Proteona Pte. Ltd. is a biomedical company in Singapore, Germany, and the US that is pioneering the use of single cell proteogenomics to improve clinical outcomes in cancer. Using a combination of innovative single cell assays and AI-assisted bioinformatics, Proteona provides a comprehensive sample to answer service that enables users to phenotype cells using standard protein markers and gain a deeper understanding of cell activity based upon their gene expression profiles. Proteona is a spin-off from the National University of Singapore (NUS) and the Agency for Science, Technology and Research (A*STAR). Proteona is leading an international alliance to develop neutralizing antibodies against coronaviruses including SARS-CoV-2. In addition, Proteona supports partners developing COVID-19 therapies and vaccines by providing single cell immune profiling services.